3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
HER2-positive Breast Cancer
4
Neoplasms
3
Multiple Myeloma
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Brain Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Salivary Gland Neoplasms
1
Resectable HER2-positive Breast Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Interventions
Exercise
21
Resistance Training
4
Counseling
3
Surveys and Questionnaires
2
Nutritional Status
2
High-Intensity Interval Training
2
Control Groups
2
lime
1
cytisine
1
Wearable Electronic Devices
1
Vitamin D
1
Transcranial Direct Current Stimulation
1
Telemedicine
1
Tablets
1
Spirometry
1
Roflumilast
1
Radiotherapy
1
Preoperative Exercise
1
Palliative Care
1
Nutrition Assessment
1
Nadolol
1
Methods
1
Memantine
1
Isoproterenol
1
Interviews as Topic
1
Hematologic Tests
1
Health Surveys
1
Health
1
Fitness Trackers
1
Exercise Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Motor Activity
×
pertuzumab
×
90 days
×
Clear all
No trials found.